Maarten E A Reith
Overview
Explore the profile of Maarten E A Reith including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
2557
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dutta A, Santra S, Harutyunyan A, Das B, Lisieski M, Xu L, et al.
Eur J Pharmacol
. 2022 Sep;
933:175286.
PMID: 36167739
No abstract available.
2.
Dutta A, Santra S, Harutyunyan A, Das B, Lisieski M, Xu L, et al.
Eur J Pharmacol
. 2022 Aug;
931:175232.
PMID: 36038378
No abstract available.
3.
Reith M, Kortagere S, Wiers C, Sun H, Kurian M, Galli A, et al.
Mol Psychiatry
. 2021 Oct;
27(2):1031-1046.
PMID: 34650206
The human dopamine transporter gene SLC6A3 has been consistently implicated in several neuropsychiatric diseases but the disease mechanism remains elusive. In this risk synthesis, we have concluded that SLC6A3 represents...
4.
Santra S, Kortagere S, Vedachalam S, Gogoi S, Antonio T, Reith M, et al.
ACS Chem Neurosci
. 2021 Apr;
12(8):1406-1418.
PMID: 33844493
We have carried out a structural exploration of (2,4,5)-2-(bis(4-fluorophenyl)methyl)-5-((4-methoxybenzyl)amino)tetrahydro-2-pyran-4-ol (D-473) to investigate the influence of various functional groups on its aromatic ring, the introduction of heterocyclic aromatic rings, and the...
5.
Jayaraman K, Das A, Luethi D, Szollosi D, Schutz G, Reith M, et al.
J Neurochem
. 2020 Aug;
157(4):919-929.
PMID: 32767560
Transporters of the solute carrier 6 (SLC6) family mediate the reuptake of neurotransmitters such as dopamine, norepinephrine, serotonin, GABA, and glycine. SLC6 family members are 12 transmembrane helix-spanning proteins that...
6.
Dutta A, Santra S, Harutyunyan A, Das B, Lisieski M, Xu L, et al.
Eur J Pharmacol
. 2019 Sep;
862:172632.
PMID: 31473161
Significant unmet needs exist for development of better pharmacotherapeutic agents for major depressive disorder (MDD) and post-traumatic stress disorder (PTSD) as the current drugs are inadequate. Our goal in this...
7.
Reith M, Gnegy M
Handb Exp Pharmacol
. 2019 Jul;
258:265-297.
PMID: 31286212
There is a plethora of amphetamine derivatives exerting stimulant, euphoric, anti-fatigue, and hallucinogenic effects; all structural properties allowing these effects are contained within the amphetamine structure. In the first part...
8.
Xu W, Reith M, Liu-Chen L, Kortagere S
Pharmacol Res
. 2019 Mar;
143:48-57.
PMID: 30844536
Agonist-induced internalization of G protein-coupled receptors (GPCRs) is a significant step in receptor kinetics and is known to be involved in receptor down-regulation. However, the dopamine D3 receptor (D3R) has...
9.
Marshall C, Brodnik Z, Mortensen O, Reith M, Shumsky J, Waterhouse B, et al.
Neuropharmacology
. 2019 Jan;
148:178-188.
PMID: 30633928
Catecholamine transmitters dopamine (DA) and norepinephrine (NE) regulate prefrontal cortical (PFC) circuit activity and PFC-mediated executive functions. Accordingly, pharmacological agents that influence catecholamine neurotransmission exert prominent effects on cognition. Many...
10.
Elmabruk A, Das B, Yedlapudi D, Xu L, Antonio T, Reith M, et al.
ACS Chem Neurosci
. 2018 Oct;
10(1):396-411.
PMID: 30301349
We have developed a series of carbazole-derived compounds based on our hybrid D/D agonist template to design multifunctional compounds for the symptomatic and disease-modifying treatment of Parkinson's disease (PD). The...